Domain Informations
Centerforbiosimilars.com lookup results from whois.godaddy.com server:
- Domain created: 2016-02-01T19:07:54Z
- Domain updated: 2022-09-20T21:34:17Z
- Domain expires: 2026-02-01T19:07:54Z 1 Year, 103 Days left
- Website age: 8 Years, 262 Days
- Registrar Domain ID: 1999350449_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- KIKI.NS.CLOUDFLARE.COM
- PETE.NS.CLOUDFLARE.COM
Network
- inetnum : 172.64.0.0 - 172.71.255.255
- name : CLOUDFLARENET
- handle : NET-172-64-0-0-1
- status : Direct Allocation
- created : 2010-07-09
- changed : 2021-07-01
- desc : All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse,Geofeed: https://api.cloudflare.com/local-ip-ranges.csv
Owner
- organization : Cloudflare, Inc.
- handle : CLOUD14
- address : Array,San Francisco,CA,94107,US
Abuse
- handle : ABUSE2916-ARIN
- name : Abuse
- phone : +1-650-319-8930
- email : [email protected]
Technical support
- handle : ADMIN2521-ARIN
- name : Admin
- phone : +1-650-319-8930
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 172.67.144.176
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 172.67.144.176)
Spam Check (IP: 172.67.144.176)
Recent Searched Sites
› Realizacursos.com.br (13 seconds ago) / US
› Emeoutlookmag.com (10 seconds ago) / US
› Naturalmodelsla.com (14 seconds ago) / US
› Comet-xray.com (3 seconds ago) / NL
› Academic-bible.com (26 seconds ago) / DE
› Centerforbiosimilars.com (1 seconds ago) / US
› Bego.dev (8 seconds ago) / US
› Bostonpda.org (1 seconds ago) / US
› My.health.nz (5 seconds ago) / US
› Ansl.edu.pl (5 seconds ago) / PL
› Canto-del-sol-hotel-puerto-vallarta.booked.mx (15 seconds ago) / US
› Christiangastaldi.centerblog.net (22 seconds ago) / FR
› Totyota.com (46 seconds ago) / CA
› Mgav88.net (10 seconds ago) / US
› Shorelinewatersports.com (18 seconds ago) / US
› Mansomanitoba.ca (1 mins ago) / CA
› Fbi11.com (20 seconds ago) / US
› Gossipannouncementf.blogspot.com (53 seconds ago) / US
› Catvp.com (28 seconds ago) / DE
› Hungaro-projekt.eu (7 seconds ago) / SK
Websites Listing
We found Websites Listing below when search with centerforbiosimilars.com on Search Engine
Center for Biosimilars®
WEB BioRationality: FDA Simplifies Glycan Profiling of mAbs, a Significant Step in Reducing the Cost of Biosimilars. By Sarfaraz K. Niazi, PhD. July 29th 2024. The FDA's new policy on glycan profiling of monoclonal antibodies (Mabs) receives praise and recommendations from Sarfaraz K. Niazi, PhD.
Centerforbiosimilars.comThe Center for Biosimilars | LinkedIn
WEB The Center for Biosimilars | 15,895 followers on LinkedIn. The authoritative resource for emerging therapies. | Health economics experts. Managed care professionals.
Linkedin.comThe Center for Biosimilars - Facebook
WEB The Center for Biosimilars, Cranbury, New Jersey. 5,396 likes · 3 talking about this. The Center for Biosimilars couples clinical and regulatory...
Facebook.comBiosimilars - AJMC
WEB The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory...
Ajmc.comMcKesson Corporation Reports Fiscal 2025 First Quarter Results
WEB McKesson Corporation (NYSE:MCK) today announced results for the first quarter of the 2025 fiscal year.
Mckesson.comEnvironment More Than Genes Impacts Age of IBD Diagnosis
WEB 3 days ago · Early-life and environmental exposures are more strongly linked to age at diagnosis of IBD than genetic factors.
Medscape.comA New Chapter: How 2023 Will Shape the US Biosimilar Space …
WEB Dec 31, 2023 · As 2023 comes to a close, we look back on some of the major advancements from the past year, from the long-awaited market introduction of adalimumab biosimilars in the US, to the first major regulatory approvals for neurology biosimilars, to the implementation of key policy initiatives around the globe.
Centerforbiosimilars.comUnited States - Center for Biosimilars®
WEB Mar 22, 2024 · Total Launched: 38. The FDA approved etanercept biosimilars in 2016 and 2019, but legal challenges from Amgen have delayed the launch of these products. …
Centerforbiosimilars.comThink you are sick? It may be the nocebo effect.
WEB 4 days ago · The opposite of the placebo efect, the nocebo effect may elicit symptoms of feeling sick, even when the intervention is a sham.
Washingtonpost.comPart 2: Unlocking the Potential of Biosimilars to Improve Health …
WEB Jun 19, 2024 · Solutions to this issue included further education among patients and physicians to attempt to close knowledge gaps while gaining trust from patients. Part 2 shifts focus onto the professional health care systems that may be imposing boundaries towards biosimilar access through a financial lens.
Centerforbiosimilars.comBioRationality: FDA Simplifies Glycan Profiling of mAbs, A …
WEB Jul 29, 2024 · The FDA's new policy on glycan profiling of monoclonal antibodies (Mabs) receives praise and recommendations from Sarfaraz K. Niazi, PhD.
Centerforbiosimilars.comPodcasts - Center for Biosimilars
WEB In this episode, The Center for Biosimilars® delves into the FDA approval of the first denosumab biosimilars, Wyost and Jubbonti (denosumab-bbdz), and discuss their potential to revolutionize osteoporosis treatment with expert insights from 2 rheumatologists.
Centerforbiosimilars.comRegulatory - Center for Biosimilars
WEB The Center for Biosimilars® looks back at the first year of adalimumab biosimilars on the US market, including every product launch and approval as well as market trends and pricing strategies.
Centerforbiosimilars.comImmunology - Center for Biosimilars
WEB Latest CME Events & Activities. Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies. August 29, 2024 | 1:00 PM & 8:00 PM ET. View More. Managed Care Approaches to Individualize Treatment of Hereditary Angioedema. September 12, 2024 | 1:00 PM & 8:00 PM ET. View More.
Centerforbiosimilars.comRheumatology - Center for Biosimilars
WEB Adalimumab Biosimilars Take Center Stage: A Game Changer for IBD Treatment. Biosimilars Rheumatology Roundup for April 2023—Podcast Edition. Pipelines and Preparation: How the US Can Prepare for More RA Biosimilars. New Year, New Hurdles: What's in Store for Biosimilars in 2023.
Centerforbiosimilars.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| unlockbiblemeaning.com | namecheap.com | -1 Years, -347 Days |
| mpark.net | networksolutions.com | 20 Days |
| kolaboo.com | ionos.com | 1 Year, 12 Days |
| freshers-recruitment.com | publicdomainregistry.com | -1 Years, -333 Days |
| lumianbartools.com | ovh.com | -1 Years, -329 Days |
| evru.org | whois.godaddy.com | -1 Years, -28 Days |
| govisitlangeland.com | one.com | -1 Years, -340 Days |
| gatherbrewing.co | whois.godaddy.com | -1 Years, -342 Days |
| planifio.com | godaddy.com | -2 Years, -174 Days |
| cavinshoes.com | publicdomainregistry.com | -1 Years, -337 Days |